Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Similarities and Differences Between Mild Cognitive Impairment and Alzheimer's Disease
Article type: Research Article
Authors: Vanmierlo, Tima; b | Bloks, Vincent W.c | van Vark-van der Zee, Leonie C.d | Rutten, Krisa | Kerksiek, Anjab | Friedrichs, Silviab | Sijbrands, Ericd | Steinbusch, Harry W.a | Kuipers, Folkertc | Lütjohann, Dieterb | Mulder, Moniquea; d; *
Affiliations: [a] Department of Neuroscience, Maastricht University, Maastricht, The Netherlands | [b] Institute of Clinical Chemistry and Pharmacology, University of Bonn, Bonn, Germany | [c] Department of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands | [d] Department of Internal Medicine, Division of Pharmacology, Vascular and Metabolic Diseases, Erasmus Medical Center, Rotterdam, The Netherlands | Sanders-Brown Center on Aging and Alzheimer's Disease Center, Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA
Correspondence: [*] Corresponding author: Dr. M. Mulder, Erasmus Medical Center, Department of Internal Medicine, Division of Pharmacology, Vascular and Metabolic Diseases, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Tel.: +31 107032707; Fax: +31 107033964; E-mail: [email protected].
Note: [] Communicated by Robert Friedland
Abstract: Disturbances in cerebral cholesterol metabolism have been implicated in the pathogenesis of Alzheimer's disease (AD). Here, we provide evidence that alterations in brain cholesterol homeostasis also can be a consequence of disease progression. We found that APPSLxPS1mut mice, at the age of 9 months when AD-like pathology starts to develop, display increased levels of the cholesterol precursor desmosterol and of the cholesterol metabolite 27-hydroxy(OH)cholesterol in their cerebellum in comparison with wild-type controls. At the age of 21 months, when APPSLxPS1mut brain contains abundant amyloid deposits, desmosterol levels had further increased (> 200% in comparison with wild-type mice) in all brain regions examined. 24(S)-OHcholesterol levels were increased in hippocampus and cerebellum of the APPSLxPS1mut mice, while 27-OHcholesterol levels were increased in cerebellum exclusively. Brain cholesterol levels remained unaffected. In line with the fact that desmosterol and 24(S)-OHcholesterol are Liver X Receptor (LXR) activators, the LXR-target genes Abca1 and Apoc1 were upregulated predominantly in hippocampus of APPSLxPS1mut mice at both ages evaluated. The reduced expression of the enzyme that converts desmosterol into cholesterol, the Selective AD indicator 1 gene (Seladin-1/Dhcr24), in both cortex and cerebellum may underlie the increased desmosterol levels in 21 month-old APPSLxPS1mut mice.
Keywords: APPSLxPS1mut, Alzheimer's disease, brain cholesterol metabolism, LXR, oxysterols, seladin
DOI: 10.3233/JAD-2010-1209
Journal: Journal of Alzheimer's Disease, vol. 19, no. 1, pp. 117-127, 2010
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]